Advertisement

Rheumatology International

, Volume 16, Issue 6, pp 249–255 | Cite as

NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-α monoclonal antibody therapy

  • D. Kalden-Nemeth
  • J. Grebmeier
  • F. Wolf
  • C. Antoni
  • B. Manger
  • J. R. Kalden
Original Article

Abstract

The aim of this study was to investigate if dynamic gadolinium-DTPA-supported magnetic resonance (MR) imaging can monitor the therapeutic effect of a fast-acting immuno-modulating drug like anti-tumour necrosis factor alpha (anti-TNF-α) monoclonal antibody (moab) in patients with rheumatoid arthritis (RA). Dynamic MR imaging was performed on 64 joints in a total of 18 patients before and after infusion with either a placebo or 1 or 10 mg/kg of anti-TNF-α moab. Additionally, treating the placebo group and reinfusing the verum group with either 3 or 10 mg/kg was monitored by quantitative nuclear magnetic resonance (NMR). Time-dependent signal intensity changes were then correlated with a total of five Paulus criteria and with ESR and C-reactive protein (CRP). No changes in either the gadolinium uptake or clinical parameters were seen after the infusion of a placebo. Therapy with 1 mg/kg anti-TNF-α moab resulted in a significant decrease in clinical disease activity, as well as in gadolinium-DTPA uptake in dynamic NMR studies. However, correlations between signal intensity changes and Paulus criteria were only demonstrated for the variable “doctor's evaluation of disease activity”. Patients given 10 mg/kg moab demonstrated a very significant improvement in all clinical manifestations of their disease, as well as a high significant reduction in gadolinium uptake (P=0.004). In addition, the latter group showed significant correlations between time-dependent signal intensity changes and five Paulus criteria: “number of swollen joints”, “number of painful joints”, “duration of morning stiffness”, “doctor's evaluation of disease activity” and “patient's evaluation of disease activity”. No differences and correlations were seen for ESR and CRP. We concluded that dynamic NMR studies are suitable to monitor inflammatory activity in RA patients under therapy with biological response modifiers such as anti-TNF-α moab.

Key words

Dynamic MRI Rheumatoid arthritis Biological response modifiers 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Buckland-Wright JC (1983) X-ray-assessment of activity in rheumatoid disease. Br J Rheumatol 22:3–10Google Scholar
  2. 2.
    Adam G, Dammer M, Bohndorf K, Christoph R, Fenke F, Gunther RW (1991) Rheumatoid arthrititis of the knee: the value of gadopentetate dimenglumine-enhanced MR imaging. AJR Am J Roentgenol (United States) Jan 1991, 156 (1) pp 125–129Google Scholar
  3. 3.
    Kursunoglu-Brahme S, Riccio T, Weisman MH, Resnick D, Zvaifler N, Sanders ME (1990) Fix: Rheumatoid knee: role of gadopentetate-enhanced MR imaging. Radiology 176:831–835PubMedGoogle Scholar
  4. 4.
    Brown DG, Edwards NL, Greer JM, Longley S, Gillesspy T, Panush RS (1990) Magnetic resonance imaging in patients with inflammatory arthritis of the knee. Clin Rheumatol 9:73–83PubMedGoogle Scholar
  5. 5.
    Bollow M, Konig H, Hoffmann C, Schilling A, Wolf KJ (1993) Erste Erfahrungen mit der dynamischen Magnetresonanztomographie in der Diagnostik entzündlicher Erkrankungen der Sakoiliakalgelenke. Rofo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 159:315–324Google Scholar
  6. 6.
    Braun J, Bollow M, Eggens U, Konig H, Distler A, Sieper J (1994) Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum (United States), 37 (7) pp 1039–1045Google Scholar
  7. 7.
    Ostergaard M, Lorenzen I, Henrikson O (1994) Dynamic gadolinium-enhanced MR imaging in active and inactive immunoinflammatory gonarthritis. Acta Radiol 35:275PubMedGoogle Scholar
  8. 8.
    Nagele M, Kunze V, Koch W, Bruning R, Seelos K, Strohmann I, Woll B, Reiser M (1993) Rheumatoid arthritis of the wrist. Dynamic Gd-DTPA enhanced MRT. Rofo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 158:141–146Google Scholar
  9. 9.
    Williams RO, Feldmann M, Maini RN (1992) Anti-tumor necrosis factor ameliorates joint disease in murine collageninduced arthritis. Proc Natl Acad Sci USA 89:9784–9788PubMedGoogle Scholar
  10. 10.
    Feldmann M, Brennan FM, Chu Cq et al. (1993) Does TNF-alpha have a pivotal role in the cytokine network in rheumatoid arthritis? In: Fiers W (ed) Tumor necrosis factor: molecular and cellular biology and clinical relevance. Karger, Basel, pp 144–152Google Scholar
  11. 11.
    Elliott ML, Maini RN, Feldmann M, et al. (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36:1681–1690PubMedGoogle Scholar
  12. 12.
    Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedGoogle Scholar
  13. 13.
    Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659Google Scholar
  14. 14.
    EULAR handbook of standard methods. Scott DL; van Riel PL, van der Heijde D, Benke AS (EULAR standin' Committee for International Clinical Studies, including clinical trials) (1993) Correspondence David L Scott, Queens College Hospital Hi London SE 5-9. ESCISIT (Chairman JS Smolen)Google Scholar
  15. 15.
    Paulus HE, Egger MJ, Ward JR, William HJ, the Cooperative Systematic Studies of Rheumatic Diseases Group, (1990) Analysis of improvement in individual rheumatoid arthritis patients treated with disease modifying anti-rheumatic drugs based on the findings in patients treated with placebo. Arthritis Rheum 33:477–484PubMedGoogle Scholar
  16. 16.
    Manger B, Kalden JR (1995) Joint and connective tissue ultrasonography — a rheumatologic bedside procedure? Arthritis Rheum 38:736–742PubMedGoogle Scholar
  17. 17.
    Docherty P, Mitchell MJ, MacMillan L, Mosher D, Barnes DC, Hanly JG (1992) Magnetic resonance imaging in detection of sacroiliitis. J Rheumatol 19:393–401PubMedGoogle Scholar
  18. 18.
    Jorgensen C, Cyteval C, Anaya JM, Baron MP, Lamarque JL, Sany L (1993) Sensitivity of magnetic resonance imaging of the wrist in very early rheumatoid arthritis. Clin Exp Rheumatol 11:163–168PubMedGoogle Scholar
  19. 19.
    Gilkeson G, Polisson R, Sinclair H, Vogler J, Rice J, Caldwell D, Spritzer C, Martinez S (1988) Early detection of carpal erosions in patients with rheumatoid arthritis: a pilot study of magnetic resonance imaging. J Rheumatol 15:1361–1366PubMedGoogle Scholar
  20. 20.
    Corvetta A, Giovagnoni A, Baldelli S, Ercolani P, Pomponio G, Luchetti MM, Rinaldi N, De Nigris E (1992) MR of rheumatoid hand lesions: comparison with conventional radiology in 31 patients. Clin Exp Rheumatol 10:217–222PubMedGoogle Scholar
  21. 21.
    Tamai K, Yamato M, Yamaguchi T, Ohno W (1994) Dynamic magnetic resonance imaging for the evaluation, of synovitis in patients with rheumatoid arthritis. Artritis Rheum 37 (8):1151–1157Google Scholar
  22. 22.
    Gaffney K, Cookson J, Blake D, Coumbe A, Blades S (1995) Quantification of rheumatoid synovitis by magnetic resonance. Arthritis Rheum 38:1610–1617PubMedGoogle Scholar
  23. 23.
    Lorenz H-M, Antoni Ch, Valerius Th, Repp R, Grünke M, Schwerdtner N, Nüßlein H, Woody J, Kalden J-R, Manger B (1996) In vivo blockade of TNF-alpha by i.v. infusion of chimeric, monoclonal TNF-alpha antibody in patients with rheumatoid arthritis: short-term cellular and molecular) effects. J Immunol (in press)Google Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • D. Kalden-Nemeth
    • 1
  • J. Grebmeier
    • 2
  • F. Wolf
    • 2
  • C. Antoni
    • 3
  • B. Manger
    • 3
  • J. R. Kalden
    • 3
  1. 1.Department of RadiologyUniversity of Erlangen-NurembergErlangenGermany
  2. 2.Department of Nuclear MedicineUniversity of Erlangen-NurembergErlangenGermany
  3. 3.Department of Internal Medicine IIIUniversity of Erlangen-NurembergErlangenGermany

Personalised recommendations